Prognostic significance of globulin/low-density lipoprotein ratio in patients with hepatocellular carcinoma after local ablative therapy: a retrospective cohort study
Open Access
- 1 October 2023
- journal article
- research article
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 12 (10) , 2533-2544
Abstract
Background: Low-density lipoprotein (LDL) and globulin (GLOB) have been found to be predictors for some malignant tumors, but their predictive value in hepatocellular carcinoma (HCC) has hardly been elucidated. This study assessed the prognostic significance of GLOB to LDL ratio (GLR) in HCC patients before ablation. Methods: This study analyzed 312 early-stage HCC patients who were hospitalized and underwent ablative treatment in Beijing You’an Hospital, Capital Medical University, from 1 January 2014 to 1 January 2019. The primary endpoint was the recurrence-free survival (RFS), calculated from treatment initiation to cancer recurrence, whereas the overall survival (OS) was measured from treatment initiation to death or last follow-up. Cox regression analysis was used to assess the GLR independently associated with recurrence and survival. OS and RFS were calculated by Kaplan-Meier analysis and compared between groups using the log rank test. The optimal cut-off value and prognostic role of GLR and other markers were evaluated via the receiver operating characteristic (ROC) curves and the Youden index. Results: Univariate and multivariate analysis found that the tumor number, tumor size, and GLR were independent risk factors of relapse, whereas etiology, tumor number, tumor size, fibrinogen (Fib), and GLR were related to OS. We classified the patients into groups with high and low levels of GLR based on the optimal cut-off value of GLR identified by ROC curve. The cumulative 1-, 3-, and 5-year RFS rates in the low GLR group were 76.4%, 53.8%, and 43.4% respectively, whereas those in the high GLR group were 71%, 31%, and 22%, respectively (P30 mm) (PConclusions: Preoperative GLR ratio has predictive value for patients with HCC who have undergone complete ablation.Keywords
This publication has 41 references indexed in Scilit:
- AASLD guidelines for the treatment of hepatocellular carcinomaHepatology, 2017
- The CXCL8-CXCR1/2 pathways in cancerCytokine & Growth Factor Reviews, 2016
- Evaluation of abnormal liver function testsPostgraduate Medical Journal, 2016
- Low pretreatment serum globulin may predict favorable prognosis for gastric cancer patientsTumor Biology, 2015
- Effect of Tumor Size on Cancer-Specific Survival in Small Hepatocellular CarcinomaMayo Clinic Proceedings, 2015
- Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI GradeJournal of Clinical Oncology, 2015
- The value of the pretreatment albumin/globulin ratio in predicting the long-term survival in colorectal cancerInternational Journal of Colorectal Disease, 2013
- Enhancers and attenuators of risk associations of chronic hepatitis B virus infection with hepatocellular carcinoma in type 2 diabetesEndocrine-Related Cancer, 2012
- Oxidized LDL: Diversity, Patterns of Recognition, and PathophysiologyAntioxidants & Redox Signaling, 2010
- Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjectsInternational Journal of Clinical and Laboratory Research, 2000